Domestic new crown vaccine: hundreds of thousands of people have been urgently vaccinated, zero infection, no case of obvious adverse reactions.

Yesterday (September 11), the news that "the domestic new crown inactivated vaccine has been urgently vaccinated hundreds of thousands of people" caused public concern.
According to Science and Technology Daily, the head of China's biology group recently on the emergency use of the new crown inactivated vaccine and overseas III. phase clinical research in an interview with the media revealed that the two new crown inactivated vaccine developed by China's national medicine has been vaccinated hundreds of thousands of times, no obvious adverse reactions, no one infected; zhou Song, general counsel of Chinese biology of
National Medicine, said that there are three clinical trials approved for the new crown inactivated vaccine in China, and chinese biology accounts for two of them, which is also the largest and largest number of emergency vaccinations at present.
It stressed that it is even more significant that the emergency use of the new corona inactivated vaccine is aimed at high-risk exposed populations, such as health care workers treating people infected with the new coronavirus, as well as diplomats to high-risk countries, foreign workers and Chinese enterprises "Belt and Road" construction personnel and so on.
tens of thousands of people have been overseas for several months after the vaccine was completed, including in areas where the outbreak occurred, there are left-behind employees infected, they are not infected.
parallel control data like this are available in many countries, which proves the effectiveness of the vaccine.
Also revealed that China National Pharmaceutical Group has invested about 2 billion yuan to build two high-grade biosecurity production workshop.
inactivated vaccine will be available as soon as the end of December.
, vice president of biology at China Pharmaceuticals, said that the new corona inactivated vaccine I., II. clinical research conducted in China, have produced a negative antibody.
", "the detection of immune antibodies is a gold standard", overseas Phase III. clinical studies, will also continue to observe the positive antibodies.
antibodies are comparable, overseas trials expand the species, countries and populations, the most important is recognized overseas, for future applications will be better.
Zhang pointed out that in the future, as long as the vaccine is approved in China, overseas countries that have conducted clinical trials will also be legally compliant.
he revealed that there are currently 500 million doses of the new corona inactivated vaccine internationally.
the price of vaccines, which is of the greatest concern to the public, Zhang Yuntao said that the overall price of vaccines will certainly be significantly lower than 1000 yuan, but has not yet set a price.
whether two or three injections will depend on the results of the trial.
if it is two stitches, it may be six months or a year to strengthen one needle, this is the most likely.
side is the acceleration of the domestic new crown vaccine market process, on the other hand, foreign new crown vaccine research and development has encountered difficulties.
AstraZeneta has announced that it will suspend an ongoing trial of a new coronavirus vaccine after a volunteer developed a suspected serious adverse reaction, the first new crown-candidate vaccine to be suspended from Phase III clinical trials.
There are reports that the serious adverse reactions caused by the above-mentioned patients are actually transverse spinal corditis, a rare disease that causes inflammation on both sides of the spinal cord, symptoms including severe pain in the body, paralysis of the limbs, urinary incontinence, sexual dysfunction, in severe cases leading to complete paralysis of the limbs.
the American medical journal Neurology, the cause of 60 percent of transverse polio cases remains unclear, with the remaining 40 percent linked to autoimmune diseases.
in rare cases, vaccines can cause transverse spinal corditis, but the disease can also be caused by viral infections.
AstraZeneta said in a statement that reports confirming that volunteers in clinical trials were suffering from transverse spinal corditis were inaccurate and that no final diagnosis had been made.
source: Medical Valley.com!-- content presentation ends -- !-- to determine whether the login ends.